Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.64 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.64 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.64 |
| ▸ | TLR2 | O60603 | 6/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.53 |
| ▸ | RRM1 | P23921 | 1/20 | 0.52 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28990465 | 0.87 | GNAI3 (0.57) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14616486 | 0.86 | GNAI3 (0.68) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL17345951 | 0.86 | GNAI3 (0.81) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14205322 | 0.84 | GNAI3 (0.65) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL30094858 | 0.84 | GNAI3 (0.65) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL20980376 | 0.84 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL20980426 | 0.84 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL24379775 | 0.84 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL14616487 | 0.83 | GNAI3 (0.63) | GNAI3GNAO1GNAI1TLR2DPP7 | |
| SCHEMBL12085597 | 0.83 | GNAI3 (0.76) | GNAI3GNAO1GNAI1TLR2DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11364200-B2 | — | — | 2022-06-21 | — | — | US | disclosed |
| US-11318099-B2 | — | — | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11364200-B2 | — | FUS, NSF, MATR3 | GNAI3 1843/4885GNAO1 2782/4885GNAI1 2044/4885 |
| US-11318099-B2 | — | FUS, NSF, MATR3 | GNAI3 1843/4885GNAO1 2782/4885GNAI1 2044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.